Navigation Links
QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
Date:10/12/2009

providing equal or better analgesia with fewer and/or less intense side effects than current standards of care.

"We are pleased to announce this manufacturing agreement with QRxPharma for MoxDuo(TM)CR; we are making significant progress with clinical formulations of this unique Dual-Opioid(TM) product," said Wes Wheeler, CEO of Patheon.

"With this agreement, the development of MoxDuo(TM)CR sets the stage to complete the MoxDuo(TM) product portfolio for managing moderate to severe pain in patients dealing with acute and chronic medical problems," Holaday said.

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of QRxPharma as of the date of this release. These forward-looking statements are not guarantees for future performance. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the stage of products under development; uncertainties relating to clinical trials; dependence on third parties; future capital needs; and risks relating to the commercialisation of the Company's proposed products.

About QRxPharma

QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system (CNS) disorders. Based on a business strategy to expand the clinical utility and commercial value of marketed and/or existing compounds, QRxPharma's product portfolio includes both late and early stage clinical drug candidates with well-defined paths to regulatory approval and sales. The Company intends to directly commercialise its products in the US and seek strategic partnerships for worldwide markets. QRxPharma's lead compound, MoxDuo(TM)IR (Q8003IR), is in Phase 3 c
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
2. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
3. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
4. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
5. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
6. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
7. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
8. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
9. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... octubre de 2014  PneumRx, Inc. ( www.pneumrx.com ... pulmonología intervencional, anunció hoy la conclusión de la ... antes de lo programado. El Estudio Clínico RENEW es ... investigación (IDE) aprobada por la FDA (Administración de ... de reducción de volumen pulmonar PneumRx RePneu, un ...
(Date:10/20/2014)... , Oct. 20, 2014  Luoxis Diagnostics, Inc., ... AMPE), today announced that its academic collaborators will ... research potential for its novel RedoxSYS Diagnostic System, ... in the body in response to injury or ... ORP as a clinical marker will be presented ...
(Date:10/20/2014)... Oct. 20, 2014 Valeritas, Inc., a leader ... patients with Type 2 diabetes, announced today that it ... Award. The award was presented October 16 th ... Columbus, Ohio . The Cardinal ... a variety of metrics specifically targeted at the importance ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3
(Date:10/20/2014)... October 20, 2014 My Clients Plus ... software application. The new module enables easy administration ... full life-cycle quality care. , This application allows users ... their practice, attach a to-do item to a specific ... even set up reoccurring reminders for follow-ups. It's ...
(Date:10/20/2014)... Oregon (PRWEB) October 20, 2014 Succeed is ... of local companies who participated in the Every Body ... is a public awareness project that encourages workers to be ... Summer Step 10,000 Program, which concluded at the end of ... variety of cities and metro areas. Participating companies gave ...
(Date:10/20/2014)... 2014 It’s hard to imagine what it’s ... vulnerable children around the world, it’s a reality. And while ... children are forced to walk barefoot on rocky terrain or ... play with their friends. , Buckner International's Shoes ... Radio in October to encourage support for Air1 and ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest hosting ... HostMonster are the best VPS hosting suppliers in ... the method of partitioning a physical server computer ... appearance and capabilities of running on someone’s own ... close attention to VPS products and related suppliers. ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2
... , All amounts are in U.S. dollars , QUEBEC CITY, ... AEZ) (the "Company"), a global biopharmaceutical company focused on endocrinology ... and for the three-month and nine-month periods ended September 30, ... - July 7, 2009. Publication in Proceedings ...
... Disability Companies are pleased to announce Newborn and Parenting Resources ... to their newborn baby and return to work after maternity ... and in-force short term disability plans offered by the affiliates ... and Parenting Resources once their baby arrives and their short ...
... LONDON, November 11 Extensive research conducted ... University of,Sheffield on the Simbionix PROcedure Rehearsal Studio(TM), was ... 2009 congress in Lisbon, Portugal. , ... year, is,the world,s first patient specific system to enable ...
... Internationally recognised ... will talk the audience through each step of the procedure as the laser treatment is ... ... iLASIK procedure in a free live broadcast. He will talk the audience through each step ...
... ... perform the latest minimally invasive single as well as double hip replacement procedures. , ... (Vocus) June 29, 2009 -- Noted ... as the 135-year-old downtown hospital,s Medical Director of Joint Replacement and Reconstruction, Dr. Thomas Whitten, ...
... ... across medical disciplines , ... Englewood, CO (Vocus) November 11, 2009 -- HEALTHeCAREERS , North America’s premier ... economy’s record unemployment rate, the medical industry continues to be one of the few ...
Cached Medicine News:Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 2Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 3Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 4Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 5Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 6Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 7Health News:WellPoint's Affiliated Life and Disability Companies Offer Newborn and Parenting Resources to Ease New Mothers' Transition Back to Work After Maternity Leave 2Health News:Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 2Health News:Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 3Health News:Eye Surgeon Broadcasts own Surgery 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 3Health News:Healthcare Web Site Boasts Thousands of Jobs in a Down Economy 2
Ideal for use with our High Beam headlight. Rotating Turret allows use with other manufacturer's cables. Infinite intensity control. Excellent color definition (6000 K Color Temperature)....
... Lite positions directly over one,eye permitting ... lens an exclusive feature ,resulting ... optic light that penetrates,deep into a ... swivel mount enables the,surgeon to rotate ...
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Halogen III Classic is,lightweight, comfortable and durable....
... a product of AlloSource, one of ... tissue processing, and Interpore Cross, a ... InterGro combines AlloGro DBM with a ... a unique bone graft that offers ...
Medicine Products: